SCHEMBL20083898

SCHEMBL20083898

O=C(Nc1ccc(F)c(CO)c1)c1cccc(CCN2CCC(O)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 3/20 0.44
▸ HTR1D P28221 3/20 0.43
▸ HTR1B P28222 3/20 0.43
▸ HTR1A P08908 2/20 0.43
▸ ACKR3 P25106 5/20 0.43
▸ TERT O14746 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HTR2A P28223 2/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ HTR7 P34969 2/20 0.41
▸ HTR6 P50406 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ CXCR3 P49682 1/20 0.41
▸ DRD2 P14416 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19157226 0.90 HTR1A (0.41) KDRHTR1DHTR1BHTR1AACKR3
SCHEMBL21844836 0.87 ACKR3 (0.51) HTR1DHTR1BHTR1AACKR3MEN1
SCHEMBL21844944 0.85 HTR1A (0.54) HTR1DHTR1BHTR1AACKR3MEN1
SCHEMBL21844837 0.84 HTR2A (0.47) HTR1DHTR1BHTR1AACKR3HTR2A
SCHEMBL21844912 0.84 MCHR1 (0.42) ACKR3ROCK2
SCHEMBL21844945 0.83 ACKR3 (0.53) ACKR3MEN1KMT2A
SCHEMBL21844943 0.81 ALDH1A1 (0.54) HTR1DHTR1BHTR1AACKR3MEN1
SCHEMBL20083956 0.80 MCHR1 (0.53) KDR
SCHEMBL15276936 0.79 KMT2A (0.59) MEN1KMT2A
SCHEMBL19157261 0.79 ACKR3 (0.49) HTR1DHTR1BHTR1AACKR3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
EP-3312160-A1 HEPATITIS B ANTIVIRAL AGENTS Novira Therapeutics Inc. (US) 2018-04-25 — — EP disclosed
Send feedback